Dr. Joe Schwarcz on the pros and cons of AstraZeneca's vaccine trials
Although the AstraZeneca vaccine is considerably cheaper, it does not boast the same efficiency as Pfizer or Moderna's vaccines.
Article content
We’re all waiting for the day when a COVID-19 vaccine will be ready so we can begin to see a glimmer of light at the end of the coronavirus pandemic “tunnel.”
With Moderna and Pfizer’s encouraging COVID-19 vaccine trials making waves last week, it’s hard not to be optimistic when a third company, AstraZeneca, sent out a press release about the trials for their vaccine.
As Dr. Joe lays out in this video, there are pros but also cons concerning the AstraZeneca vaccine trials.
All our coronavirus-related news can be found at montrealgazette.com/tag/coronavirus.
Sign up for our email newsletter dedicated to local COVID-19 coverage at montrealgazette.com/coronavirusnews.
Help support our local journalism by subscribing to the Montreal Gazette here.
Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information.